{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:53:48Z","timestamp":1791345228179,"version":"4.3.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007065","name":"Universit\u00e0 degli Studi di Salerno","doi-asserted-by":"publisher","award":["D43C22001200001"],"award-info":[{"award-number":["D43C22001200001"]}],"id":[{"id":"10.13039\/501100007065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007065","name":"Universit\u00e0 degli Studi di Salerno","doi-asserted-by":"publisher","award":["CN00000041"],"award-info":[{"award-number":["CN00000041"]}],"id":[{"id":"10.13039\/501100007065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["2023 FGI 0012"],"award-info":[{"award-number":["2023 FGI 0012"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016019","name":"Federal State of Thuringia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1278\/2 Polytarget 316213987"],"award-info":[{"award-number":["SFB1278\/2 Polytarget 316213987"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1127\/3 ChemBioSys 239748522"],"award-info":[{"award-number":["SFB 1127\/3 ChemBioSys 239748522"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004403","name":"Th\u00fcringer Aufbaubank","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.biopha.2025.118190","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T20:11:07Z","timestamp":1748635867000},"page":"118190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Uncovering anti-inflammatory natural products that synergize with supplemented omega-3 PUFA for eliciting endogenous inflammation resolution signals"],"prefix":"10.1016","volume":"188","author":[{"given":"Paul M.","family":"Jordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas K.","family":"Peltner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2246-1682","authenticated-orcid":false,"given":"Vivien","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2865-9811","authenticated-orcid":false,"given":"Philipp","family":"Dahlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8426-4216","authenticated-orcid":false,"given":"Lorenz","family":"Thost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea Celine","family":"H\u00f6rcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6350-9052","authenticated-orcid":false,"given":"Vivien","family":"Nischang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Temml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-4379","authenticated-orcid":false,"given":"Oliver","family":"Werz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118190_bib1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118190_bib2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1126\/science.abi5200","article-title":"The spectrum of inflammatory responses","volume":"374","author":"Medzhitov","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.118190_bib3","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2025.118190_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.1230720","article-title":"Anti-inflammatory therapy in chronic disease: challenges and opportunities","volume":"339","author":"Tabas","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.118190_bib5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.cell.2015.02.010","article-title":"Homeostasis, inflammation, and disease susceptibility","volume":"160","author":"Kotas","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118190_bib6","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2025.118190_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/EBC20190083","article-title":"Eicosanoids","volume":"64","author":"Calder","year":"2020","journal-title":"Essays Biochem"},{"key":"10.1016\/j.biopha.2025.118190_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118190_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem"},{"key":"10.1016\/j.biopha.2025.118190_bib10","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2025.118190_bib11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2025.118190_bib12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/bph.14336","article-title":"Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology","volume":"176","author":"Dalli","year":"2019","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118190_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114759","article-title":"Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: The battle between pro- and anti-inflammatory lipid mediators","volume":"193","author":"Gilbert","year":"2021","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118190_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/1-4020-5688-5_1","article-title":"Anti-inflammatory drugs in the 21st century","volume":"42","author":"Rainsford","year":"2007","journal-title":"Subcell. Biochem"},{"key":"10.1016\/j.biopha.2025.118190_bib15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/9550","article-title":"Inducible cyclooxygenase may have anti-inflammatory properties","volume":"5","author":"Gilroy","year":"1999","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2025.118190_bib16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2310\/JIM.0b013e31819aaa76","article-title":"The anti-inflammatory effects of prostaglandins","volume":"57","author":"Scher","year":"2009","journal-title":"J. Invest. Med"},{"key":"10.1016\/j.biopha.2025.118190_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrrheum.2016.193","article-title":"Immune resolution mechanisms in inflammatory arthritis","volume":"13","author":"Perretti","year":"2017","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.biopha.2025.118190_bib18","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMcibr1511280","article-title":"Resolvin Infectious Inflammation by Targeting the Host Response","volume":"373","author":"Lee","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2025.118190_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-023-00984-x","article-title":"Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease","author":"Fredman","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2025.118190_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108247","article-title":"Staphylococcus aureus-Derived alpha-Hemolysin Evokes Generation of Specialized Pro-resolving Mediators Promoting Inflammation Resolution","volume":"33","author":"Jordan","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2025.118190_bib21","article-title":"Allosteric activation of 15-lipoxygenase-1 by boswellic acid induces the lipid mediator class switch to promote resolution of inflammation","author":"Borner","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2025.118190_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105556","article-title":"Anti-inflammatory celastrol promotes a switch from leukotriene biosynthesis to formation of specialized pro-resolving lipid mediators","volume":"167","author":"Pace","year":"2021","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118190_bib23","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.chembiol.2023.08.001","article-title":"Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators","volume":"30","author":"Peltner","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.biopha.2025.118190_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114825","article-title":"Natural chalcones elicit formation of specialized pro-resolving mediators and related 15-lipoxygenase products in human macrophages","volume":"195","author":"Kretzer","year":"2022","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118190_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103142","article-title":"Protocol for lipid mediator profiling and phenotyping of human M1- and M2-monocyte-derived macrophages during host-pathogen interactions","volume":"5","author":"G\u00fcnther","year":"2024","journal-title":"STAR Protoc."},{"key":"10.1016\/j.biopha.2025.118190_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108775","article-title":"Influenza A virus selectively elevates prostaglandin E(2) formation in pro-resolving macrophages","volume":"27","author":"Jordan","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2025.118190_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.05.011","article-title":"In vivo sex differences in leukotriene biosynthesis in zymosan-induced peritonitis","volume":"87","author":"Rossi","year":"2014","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118190_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41467-017-02538-5","article-title":"Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity","volume":"9","author":"Werz","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118190_bib29","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1096\/fj.201802509R","article-title":"Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome","volume":"33","author":"Werner","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2025.118190_bib30","doi-asserted-by":"crossref","first-page":"9201","DOI":"10.1021\/acs.jmedchem.3c00831","article-title":"Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis","volume":"66","author":"Musella","year":"2023","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2025.118190_bib31","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0006-2952(02)01387-4","article-title":"Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase","volume":"64","author":"Albert","year":"2002","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118190_bib32","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1021\/jm500308c","article-title":"SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase","volume":"57","author":"Koeberle","year":"2014","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2025.118190_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41589-020-0544-7","article-title":"Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products","author":"Gilbert","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2025.118190_bib34","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1007\/s00018-019-03393-x","article-title":"Exotoxins from Staphylococcus aureus activate 5-lipoxygenase and induce leukotriene biosynthesis","volume":"77","author":"Romp","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2025.118190_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2012.07.022","article-title":"Expression and regulation of 12\/15-lipoxygenases in human primary macrophages","volume":"225","author":"Wuest","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2025.118190_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107879","article-title":"Resolution of inflammation: An organizing principle in biology and medicine","volume":"227","author":"Panigrahy","year":"2021","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118190_bib37","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2025.118190_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions","volume":"206","author":"Serhan","year":"2009","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2025.118190_bib39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118190_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biochi.2020.08.015","article-title":"Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake","volume":"178","author":"Calder","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2025.118190_bib41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bcp.2010.09.025","article-title":"Arzanol, a prenylated heterodimeric phloroglucinyl pyrone, inhibits eicosanoid biosynthesis and exhibits anti-inflammatory efficacy in vivo","volume":"81","author":"Bauer","year":"2011","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118190_bib42","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.bcp.2009.02.005","article-title":"Identification of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 as functional targets of the anti-inflammatory and anti-carcinogenic garcinol","volume":"77","author":"Koeberle","year":"2009","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118190_bib43","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1476-5381.2009.00070.x","article-title":"Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1","volume":"156","author":"Koeberle","year":"2009","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118190_bib44","article-title":"Pharmacology, toxicity, bioavailability, and formulation of magnolol: an update","volume":"12","author":"Lin","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118190_bib45","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2147\/JIR.S345510","article-title":"Shifting the biosynthesis of leukotrienes toward specialized pro-resolving mediators by the 5-lipoxygenase-activating protein (FLAP) antagonist BRP-201","volume":"15","author":"Kretzer","year":"2022","journal-title":"J. Inflamm. Res"},{"key":"10.1016\/j.biopha.2025.118190_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1219160","article-title":"Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators","volume":"14","author":"Dahlke","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118190_bib47","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.drudis.2014.08.006","article-title":"Multi-target approach for natural products in inflammation","volume":"19","author":"Koeberle","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2025.118190_bib48","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.biotechadv.2018.02.010","article-title":"Natural products as inhibitors of prostaglandin E2 and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis","volume":"36","author":"Koeberle","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biopha.2025.118190_bib49","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbalip.2018.07.002","article-title":"Selectivity of phospholipid hydrolysis by phospholipase A2 enzymes in activated cells leading to polyunsaturated fatty acid mobilization","volume":"1864","author":"Astudillo","year":"2019","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.biopha.2025.118190_bib50","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1084\/jem.20121887","article-title":"Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators","volume":"210","author":"Miki","year":"2013","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2025.118190_bib51","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ajg.2012.13","article-title":"Prescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patients","volume":"107","author":"Lanas","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118190_bib52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tips.2023.01.001","article-title":"Rethinking the use of NSAIDs in early acute pain","volume":"44","author":"Sisignano","year":"2023","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118190_bib53","article-title":"Frankincense preparation promotes formation of inflammation-resolving lipid mediators by manipulating lipoxygenases in human innate immune cells","volume":"14","author":"Nischang","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118190_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/nu15173848","article-title":"Efficacy of boswellia serrata extract and\/or an omega-3-based product for improving pain and function in people older than 40 years with persistent knee pain: a randomized double-blind controlled clinical trial","volume":"15","author":"P\u00e9rez-Pi\u00f1ero","year":"2023","journal-title":"Nutrients"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225003841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225003841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:46:51Z","timestamp":1777574811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225003841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":54,"alternative-id":["S0753332225003841"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118190","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncovering anti-inflammatory natural products that synergize with supplemented omega-3 PUFA for eliciting endogenous inflammation resolution signals","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118190"}}